Intratumoral Genomic Heterogeneity May Hinder Precision Medicine Strategies in Patients with Serous Ovarian Carcinoma

number of downloads : ?

Use this link to cite this item : https://ir.lib.shimane-u.ac.jp/52763

language	eng
Author	Nakamura, Kohei 1 Genomics Unit, Keio Cancer Center, Keio University School of Medicine, 35 Shinanomachi, Shinjukuku, Tokyo 160-8582, Japan 2 Department of Obstetrics and Gynecology, Kumagaya General Hospital, Saitama 360-8657, Japan Aimono, Eriko Genomics Unit, Keio Cancer Center, Keio University School of Medicine, 35 Shinanomachi, Shinjukuku, Tokyo 160-8582, Japan Tanishima, Shigeki Department of Biomedical Informatics, Kansai Division, Mitsubishi Space Software Co., Ltd, Tokyo 661-0001, Japan Imai, Mitsuho Genomics Unit, Keio Cancer Center, Keio University School of Medicine, 35 Shinanomachi, Shinjukuku, Tokyo 160-8582, Japan Kawano Nagatsuma, Akiko Genomics Unit, Keio Cancer Center, Keio University School of Medicine, 35 Shinanomachi, Shinjukuku, Tokyo 160-8582, Japan Hayashi, Hideyuki Genomics Unit, Keio Cancer Center, Keio University School of Medicine, 35 Shinanomachi, Shinjukuku, Tokyo 160-8582, Japan Yoshimura, Yuki Department of Obstetrics and Gynecology, Shimane University School of Medicine, Enyacho 89-1, Izumo 693-8501, Japan NAKAYAMA, Kentaro KYO, Satoru Nishihara, Hiroshi Genomics Unit, Keio Cancer Center, Keio University School of Medicine, 35 Shinanomachi, Shinjukuku, Tokyo 160-8582, Japan
Subject	ovarian carcinoma; genomic heterogeneity; precision medicine; DNA sequencing
Journal Title	DIAGNOSTICS
Volume	10
Issue	4
ISSN（Online）	2075-4418
Published Date	2020-04
DOI	10.3390/diagnostics10040200
PubMed ID	32260152
Publisher	MDPI
NII Type	Journal Article
OAI-PMH Set	Faculty of Medicine
Remark	This study was supported by the JSPS KAKENHI (Grant-in-Aid for Young Scientists B) Grant Number 20K18232, and the Japan Agency for Medical Research and Development (AMED) under grant number JP 16kk0205006.